CD274 and pancreatic ductal adenocarcinoma: In mouse models of pancreatic ductal adenocarcinoma, either tumor-cell-specific depletion or pharmacologic inhibition of GR led to PD-L1 downregulation and MHC-I upregulation, which in turn promoted the activity of cytotoxic T cells to enhance anti-tumor immunity.